LeafBio's Option/Warrant Round

LeafBio raised a round of funding on October 12, 2018.

LeafBio is the commercialization arm of Mapp Biopharmaceutical. The company focuses on pharmaceutical research and development of monoclonal antibody products for the treatment and prevention of viral…

Articles about LeafBio's Option/Warrant Round: